May 25, 2024, 09:12
Sankalp Arora: Excited to be presenting longterm follow up results of AZA + RUX in patients with myelofibrosis at ASCO24
Sankalp Arora, Heme/Onc fellow at MD Anderson Cancer Center, shared on X/Twitter:
“The ASCO24 countdown begins!
Excited to be presenting longterm follow up results of phase 2 clinical trial at MD Anderson Cancer Center evaluating AZA + RUX combination therapy in patients with myelofibrosis.
Source: Sankalp Arora/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 23, 2024, 16:25
Oct 23, 2024, 16:03
Oct 23, 2024, 15:44
Oct 23, 2024, 15:44
Oct 23, 2024, 15:42
Oct 23, 2024, 15:15